Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 28/01/2010 Rentschler Biotechnologie Logo

    Kenta and Rentschler to develop antibodies against hospital-acquired infections

    The young Swiss company Kenta Biotech will work with the Laupheim-based contract manufacturer Rentschler to develop a fully human monoclonal antibody against methicillin-resistant Staphylococcus aureus (MRSA).

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/kenta-and-rentschler-to-develop-antibodies-against-hospital-acquired-infections
  • Press release - 14/01/2010 Different Arabidopsis plants (Photo: Max Planck Society)

    Evolution caught in the act

    Mutations are the raw material of evolution. Charles Darwin already recognized that evolution depends on heritable differences between individuals: those who are better adapted to the environment have better chances to pass on their genes to the next generation. A species can only evolve if the genome changes through new mutations, with the best new variants surviving the sieve of selection. Scientists at the Max Planck Institute for…

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/evolution-caught-in-the-act
  • Press release - 14/01/2010 10498_de.jpg

    Deep brain stimulation successful for treatment of severely depressive patient

    A team of neurosurgeons at Heidelberg University Hospital and psychiatrists at the Central Institute of Mental Health, Mannheim have for the first time successfully treated a patient suffering from severe depression by stimulating the habenula, a tiny nerve structure in the brain. The 64-year-old woman, who had suffered from depression since age 18, could not be helped by medication or electroconvulsive therapy. Since the procedure, she is for…

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/deep-brain-stimulation-successful-for-treatment-of-severely-depressive-patient
  • Press release - 23/12/2009 Portrait of Prof. Dr. Frank Kirchhoff

    The spread of HIV: optimal adaptation to the human host

    A new study led by the virologist and Leibniz Award winner Frank Kirchhoff from Ulm might be about to provide an explanation as to why only one of several independent transmissions of simian immunodeficiency viruses (SIV) from chimpanzees to humans led to the global AIDS pandemic. The researchers now hope that these new findings will contribute to the search for new strategies to prevent the further spread of AIDS viruses.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/the-spread-of-hiv-optimal-adaptation-to-the-human-host
  • Article - 16/12/2009

    BioValley “Science meets Business Day 2009”

    This year’s presentations at the “Science meets Business Day 2009” once again showed that the exchange between science and the industry in the BioValley works extraordinarily well. The “Science meets Business Day 2009” concluded this year’s BioValley Life Science Week, where researchers from five completely different disciplines and their industrial partners presented their views on what makes the economic location in the area bordered by…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/biovalley-science-meets-business-day-2009
  • Article - 15/12/2009 10405_de.jpg

    AppliedSensor GmbH – Chemical gas sensors to detect contaminants

    Sensors and sensor systems are the speciality of Reutlingen-based AppliedSensor GmbH. The company develops gas detectors for the detection of harmful inorganic and volatile organic compounds. The application of the detectors is as broad as the presence of such gases, and they can be used anywhere from small family houses to offices, from cattle sheds to cars.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/appliedsensor-gmbh-chemical-gas-sensors-to-detect-contaminants
  • Press release - 08/12/2009 10296_de.jpg

    Vaccination of honeybees against the Varroa mite is possible

    For the first time ever, honeybees were orally ‚vaccinated’ with a genetically engineered product that was later detected in the bloodsucking Varroa mite. This product is a DNA-plasmid that is normally used for man, horses, swine and also for fish. The inventor of this innovative DNA-vaccination system for bees is Matthias Giese, PhD, who launches his own Institute for Molecular Vaccines (IMV) in Heidelberg/Germany starting in 2010.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/vaccination-of-honeybees-against-the-varroa-mite-is-possible
  • Press release - 03/12/2009 10264_de.jpg

    ELARA Pharmaceuticals receives EUR 4.6 Million funding

    ELARA Pharmaceuticals GmbH, a biotech company focused on the development of drugs for the treatment of different cancers, announced today the closing of a € 2.6 million Series A financing round, which will trigger an additional € 2 million from the BMBF GOBio and the Biotechnologie Rhein-Neckar (BioRN) Spitzencluster programs, leading to a total funding of € 4.6 million.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/elara-pharmaceuticals-receives-eur-4-6-million-funding
  • Article - 03/12/2009 10296_de.jpg

    Matthias Giese: DNA vaccine to combat worldwide honeybee deaths

    Varroa mites attach to the body of bees and weaken them by sucking hemolymph infecting them with viruses that are believed to be the cause of the mass death of European honeybee colonies. Matthias Giese of the Heidelberg-based Institute for Molecular Vaccines developed a DNA vaccine that might just lead to a breakthrough in the quest to get rid of the Varroa parasites. Giese tells us about his project in the following interview.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/matthias-giese-dna-vaccine-to-combat-worldwide-honeybee-deaths
  • Article - 19/11/2009 Prof. Iwona Adamska and biologist Jens Lohscheider working at a clean bench in the laboratory

    Iwona Adamska helps plants exposed to light stress

    Light is a vital element for plants. They require light to carry out photosynthesis and to produce their body substance from inorganic substances such as water and carbon dioxide. On the other hand plants can also suffer from too much light. Plants have developed a number of protective mechanisms to survive light stress situations. The biologist Prof. Iwona Adamska from the University of Constance is looking closely into these protective…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/iwona-adamska-helps-plants-exposed-to-light-stress
  • Article - 16/11/2009 Logo of the ERA-Net vSEED project. The logo shows four differently coloured plant seeds from where computer cables emerge.<br />

    New network for systems biology seed research

    What happens to plant seeds during germination? Researchers led by Dr. Gerhard Leubner from the University of Freiburg in collaboration with six international groups of researchers will be jointly looking into these processes. The virtual Seed (vSEED) consortium took first place in a field of 54 contestants in the European Research Era-Net Plant Genomics competition. What makes the scientists’ project so special is that they are planning to…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/new-network-for-systems-biology-seed-research
  • Article - 05/11/2009 10032_de.jpg

    The abatement of phytopathological fungi

    In the past, fungal infestation of agricultural crops has been known to affect the fate of entire nations, and nowadays it still continues to pose a threat to the world’s food supply. There is huge need for the development of new environmentally friendly agricultural fungicides, as fungi are fast becoming resistant to standard fungicides. Scientists are concentrating on the use of fungus-derived natural substances as the specific targets of…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/the-abatement-of-phytopathological-fungi
  • Article - 28/10/2009 The photo shows a green wine leaf with many red spots.

    State Viticulture Institute to combat mildew

    Powdery and downy mildew can destroy entire wine harvests. More than 150 years ago, breeders attempted to increase the plants’ natural resistance to mildew by crossing them with more mildew-resistant grape varieties as an alternative to external abatements using fungicides. The majority of breeders soon abandoned the effort; only a handful of breeders, including biologists from the State Viticulture Institute in Freiburg, still believed that this…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/state-viticulture-institute-to-combat-mildew
  • Press release - 12/10/2009 The photo shows Dr. Friesen holding a substance-containing vial.

    Methadone for treating brain tumours - finally an effective therapy in sight?

    Every year, around 5,500 people in Germany are diagnosed with malignant brain tumours. The chances of effectively treating patients with such tumours have barely improved over the last decades. A new therapeutic appears to be promising. Scientists at the Institute of Forensic Medicine at the University Hospital of Ulm have been able to show that methadone has the ability to combat brain tumours.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/methadone-for-treating-brain-tumours-finally-an-effective-therapy-in-sight
  • Press release - 24/09/2009

    Evidence for the expression of both DNA strands

    A group of researchers led by Prof. Hess at the University of Freiburg reports on the use of both strands of the DNA double helix during the copying of the genetic information encoded by the genes. As reported in the renowned scientific magazine Molecular Systems Biology, the antisense RNA created during this process can contribute to the development of new therapeutic concepts.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/evidence-for-the-expression-of-both-dna-strands
  • Press release - 18/09/2009

    Why don’t brain tumours respond to drugs?

    Malignant brain tumours do not often respond to promising new drugs. Researchers from Heidelberg have now uncovered a mechanism and a tumour marker that are linked to the development of this resistance. A “death receptor” might possibly indicate the chances of success of chemotherapy at the same time as providing new approaches for developing a new therapy for the successful treatment of brain tumours.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/why-don-t-brain-tumours-respond-to-drugs
  • Press release - 01/09/2009 09511_de.jpg

    Seal of quality for hygienic equipment

    The processing and packaging of food is governed by very strict hygiene rules. Researchers are now testing production equipment for cleanroom suitability and are listing qualified products in an online database.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/seal-of-quality-for-hygienic-equipment
  • Article - 04/08/2009 09305_de.jpg

    Wilfried Weber recombines new cell constituents

    Prof. Dr. Wilfried Weber who was appointed professor of synthetic biology at the Centre for Biological Signalling Studies bioss at the University of Freiburg in May 2009 has always had a great interest in the practical application of biology. Weber and his team have a thorough understanding of how different parts of signalling networks can be reassembled for specific purposes for example switching off the antibiotic resistance of bacteria.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/wilfried-weber-recombines-new-cell-constituents
  • Article - 23/07/2009 09223_de.jpg

    Making cancer cells commit suicide

    They divide and divide, and no natural border can stop them. Tumours such as the Ewing sarcoma, a bone cancer that occurs predominantly in teenagers, grow incessantly, making treatment difficult. A few years ago, Prof. Dr. Udo Kontny and his team from the University Hospital in Freiburg discovered a way to stop the growth of this particular tumour by activating a switch on the surface of cells which induces cellular death. Can physicians learn to…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/making-cancer-cells-commit-suicide
  • Dossier - 16/07/2009 09218_de.jpg

    Patents – the exploitations of inventions in the life sciences

    According to statistics from the European Patent Office a total of 1065 biotechnological patents were filed in 2007 by inventors based in Germany. This puts Germany second behind the USA. In the coming years experts expect that a much larger number of biotech patents will be filed. For life sciences inventors the registration of patents quite often represents a real challenge. People entering the world of patents and licences are faced with a…

    https:////www.gesundheitsindustrie-bw.de/en/article/dossier/patents-the-exploitations-of-inventions-in-the-life-sciences
  • Article - 02/07/2009 HCMV has been detected in a renal artery organ model. The electron microscope image clearly shows the spiky spherical pathogen.

    A virus that hides while it waits for an opportunity to replicate

    Thomas Mertens, Medical Director of the Institute of Virology in Ulm, has a strong scientific and clinical interest in the human cytomegalovirus (HCMV), a big virus with a big impact which, despite its size, is overshadowed by known viruses such as the HI virus that is the object of research for Mertens’ colleagues. HCMV research is a challenging area where quick successes are rare.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/a-virus-that-hides-while-it-waits-for-an-opportunity-to-replicate
  • Press release - 22/06/2009 08887_de.jpg

    Many animal experiments are superfluous

    Researchers at the Esslingen University of Applied Sciences are working on an alternative to the large number of animal experiments that are still being carried out. Researchers under the leadership of Prof. Dr. Bettina Weiß have received a grant from the Landesstiftung Baden-Württemberg foundation for work on this particular research area.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/many-animal-experiments-are-superfluous
  • Article - 12/05/2009 Prof. Dr. Martin Wabitsch was head of a weight reduction programme (Obeldicks) for children. The photo shows him together with oecotrophologist Maleika Fuchs.

    Fatal relatives: adiposity and diabetes

    Martin Wabitsch was the first German pediatrician to investigate adiposity back when it was seen as a strange subject to study. Nowadays, in Germany the attitude towards adiposity has completely changed. More and more people are suffering from adiposity and diabetes and are consequently at risk of contracting other severe diseases as a result. In children and young adults the situation is alarming; many children are at risk of contracting…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/fatal-relatives-adiposity-and-diabetes
  • Dossier - 11/05/2009 08594_de.jpg

    Diabetes, a danger that is still underestimated

    In 2010 there will be 10 million diabetes patients in Germany and nearly 33 millions in Europe. The diabetes avalanche is rolling and what is Germany doing? So far so little say experts. There is a lot happening at the same time in different places little is evaluated and a lot is lost in the maelstrom of individual interests. The figures are clear The metabolic disease known as diabetes has reached the proportions of a worldwide epidemic. It not…

    https:////www.gesundheitsindustrie-bw.de/en/article/dossier/diabetes-a-danger-that-is-still-underestimated
  • Article - 11/05/2009 The cancer stem cell (CSC) hypothesis

    Metastasis-inducing cancer stem cells

    Just a small subpopulation of cancer cells namely metastasis-inducing cancer stem cells MICs is potentially responsible for the formation of distant malignant tumour metastases. The characterisation of MICs and the clarification of mechanisms that lead to their reactivation from a dormant state opens up new strategies for the development of new effective therapies against metastasising tumours.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/metastasis-inducing-cancer-stem-cells

Page 7 / 9

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2021
Website address: https://www.gesundheitsindustrie-bw.de/en/search